These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 23933338

  • 1. Epitope engineering and molecular metrics of immunogenicity: a computational approach to VLP-based vaccine design.
    Joshi H, Lewis K, Singharoy A, Ortoleva PJ.
    Vaccine; 2013 Oct 01; 31(42):4841-7. PubMed ID: 23933338
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.
    O'Rourke JP, Peabody DS, Chackerian B.
    Curr Opin Virol; 2015 Apr 01; 11():76-82. PubMed ID: 25829254
    [Abstract] [Full Text] [Related]

  • 4. Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins.
    Zhang X, Xin L, Li S, Fang M, Zhang J, Xia N, Zhao Q.
    Hum Vaccin Immunother; 2015 Apr 01; 11(5):1277-92. PubMed ID: 25751641
    [Abstract] [Full Text] [Related]

  • 5. Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.
    Yong CY, Yeap SK, Goh ZH, Ho KL, Omar AR, Tan WS.
    Appl Environ Microbiol; 2015 Feb 01; 81(3):882-9. PubMed ID: 25416760
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Major findings and recent advances in virus-like particle (VLP)-based vaccines.
    Mohsen MO, Zha L, Cabral-Miranda G, Bachmann MF.
    Semin Immunol; 2017 Dec 01; 34():123-132. PubMed ID: 28887001
    [Abstract] [Full Text] [Related]

  • 10. Virus-like particles produced in plants as potential vaccines.
    Scotti N, Rybicki EP.
    Expert Rev Vaccines; 2013 Feb 01; 12(2):211-24. PubMed ID: 23414411
    [Abstract] [Full Text] [Related]

  • 11. Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus.
    Mobini S, Chizari M, Mafakher L, Rismani E, Rismani E.
    Front Immunol; 2020 Feb 01; 11():2074. PubMed ID: 33042118
    [Abstract] [Full Text] [Related]

  • 12. Recent advancements in combination subunit vaccine development.
    Tan M, Jiang X.
    Hum Vaccin Immunother; 2017 Jan 02; 13(1):180-185. PubMed ID: 27649319
    [Abstract] [Full Text] [Related]

  • 13. Screen of multifunctional monoclonal antibodies against hepatitis B core virus-like particles.
    Sun C, Ding FX, Wang F, He XW, He Y, Li ZS, Sun SH.
    Microbiol Immunol; 2009 Jun 02; 53(6):340-8. PubMed ID: 19493202
    [Abstract] [Full Text] [Related]

  • 14. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
    Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, Chi WK, Lin AN, Chiang BL.
    Vaccine; 2012 Feb 08; 30(7):1305-12. PubMed ID: 22214888
    [Abstract] [Full Text] [Related]

  • 15. Virus-like particles: potential veterinary vaccine immunogens.
    Liu F, Ge S, Li L, Wu X, Liu Z, Wang Z.
    Res Vet Sci; 2012 Oct 08; 93(2):553-9. PubMed ID: 22100244
    [Abstract] [Full Text] [Related]

  • 16. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.
    Mulder AM, Carragher B, Towne V, Meng Y, Wang Y, Dieter L, Potter CS, Washabaugh MW, Sitrin RD, Zhao Q.
    PLoS One; 2012 Oct 08; 7(4):e33235. PubMed ID: 22493667
    [Abstract] [Full Text] [Related]

  • 17. Virus-like particles in picornavirus vaccine development.
    Dong H, Guo HC, Sun SQ.
    Appl Microbiol Biotechnol; 2014 May 08; 98(10):4321-9. PubMed ID: 24647496
    [Abstract] [Full Text] [Related]

  • 18. Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine.
    Hankaniemi MM, Stone VM, Andrejeff T, Heinimäki S, Sioofy-Khojine AB, Marjomäki V, Hyöty H, Blazevic V, Flodström-Tullberg M, Hytönen VP, Laitinen OH.
    Antiviral Res; 2019 Nov 08; 171():104595. PubMed ID: 31491431
    [Abstract] [Full Text] [Related]

  • 19. Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli.
    Lagoutte P, Mignon C, Donnat S, Stadthagen G, Mast J, Sodoyer R, Lugari A, Werle B.
    J Virol Methods; 2016 Jun 08; 232():8-11. PubMed ID: 26947397
    [Abstract] [Full Text] [Related]

  • 20. Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV.
    Wang YS, Ouyang W, Liu XJ, He KW, Yu SQ, Zhang HB, Fan HJ, Lu CP.
    Vaccine; 2012 Mar 09; 30(12):2125-30. PubMed ID: 22285269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.